Works by Yanhua Ding

Results: 90

Safety, pharmacokinetics, preliminary efficacy, pharmacodynamics, and immunogenicity of QX002N, an anti-IL-17A monoclonal antibody, after short-term treatment of active ankylosing spondylitis.

Published in:

BMC Pharmacology & Toxicology, 2025, v. 26, n. 1, p. 1, doi. 10.1186/s40360-025-00885-4

By:

Wu, Min;
Li, Qianqian;
Fang, Min;
Zhang, Hong;
Ding, Yanhua

Publication type:

Article

Pharmacokinetics and Safety of TPN171 (a PDE5 Inhibitor) in Patients With Mild or Moderate Hepatic Impairment Versus Participants With Normal Hepatic Function: A Phase 1 Study.

Published in:

Clinical Pharmacology in Drug Development, 2025, v. 14, n. 6, p. 472, doi. 10.1002/cpdd.1535

By:

Zhou, Jing;
Zhang, Hong;
Ding, Yanhua;
Wang, Zhen;
Wang, Yu;
Juan, Jiaxiang;
Jiang, Zhicheng;
Chen, Hong

Publication type:

Article

A Reference‐Scaled Average Bioequivalence Study of Azithromycin Tablets Manufactured in China and the United States: An Open‐Label, Randomized, Single‐Dose, 3‐Way Crossover Study in Healthy Chinese Subjects Under Fasted and Fed Conditions

Published in:

Clinical Pharmacology in Drug Development, 2022, v. 11, n. 10, p. 1147, doi. 10.1002/cpdd.1132

By:

Ge, Beikang;
Li, Cuiyun;
Wei, Hua;
Ding, Yanhua;
Wu, Min;
Liu, Yuwang;
Zhang, Kaiting;
Peng, Ao

Publication type:

Article

Comparison of the Pharmacokinetics of Generic Versus Branded Obeticholic Acid in a Chinese Population: Effects of Food and Sex.

Published in:

Clinical Pharmacology in Drug Development, 2021, v. 10, n. 7, p. 797, doi. 10.1002/cpdd.905

By:

Li, Xiaojiao;
Zhang, Hong;
Li, Cuiyun;
Zheng, Wenbo;
Wang, Meng;
Wu, Min;
Yang, Deming;
Hu, Yue;
Huo, Dandan;
Xu, Zhongnan;
Ding, Yanhua;
Liu, Li

Publication type:

Article

Pharmacokinetics and Safety of Chiglitazar, a Peroxisome Proliferator‐Activated Receptor Pan‐Agonist, in Patients < 65 and ≥ 65 Years With Type 2 Diabetes.

Published in:

Clinical Pharmacology in Drug Development, 2021, v. 10, n. 7, p. 789, doi. 10.1002/cpdd.893

By:

Li, Xiaojiao;
Yu, Jia;
Wu, Min;
Li, Qianqian;
Liu, Jingrui;
Zhang, Hong;
Zhu, Xiaoxue;
Li, Cuiyun;
Zhang, Jinwen;
Ning, Zhiqiang;
Ding, Yanhua

Publication type:

Article

Clinical Evaluation of the Tolerability and Pharmacokinetics of Azilsartan, a Potent Angiotensin Receptor Blocker, in Healthy Chinese Subjects.

Published in:

Clinical Pharmacology in Drug Development, 2020, v. 9, n. 4, p. 505, doi. 10.1002/cpdd.735

By:

Li, Xiaojiao;
Liu, Jingrui;
Sheng, Changcheng;
Chen, Hong;
Cui, Dongyang;
Chen, Guiling;
Zhang, Hong;
Zhu, Xiaoxue;
Wu, Min;
Li, Cuiyun;
Shen, Zhenwei;
Guo, Yingjie;
Ding, Yanhua;
Jiao, Zheng

Publication type:

Article

Clinical Evaluation of the Tolerability, Pharmacokinetics, and Inhibition of Platelet Aggregation of Eptifibatide in Healthy Chinese Subjects.

Published in:

Clinical Pharmacology in Drug Development, 2020, v. 9, n. 2, p. 267, doi. 10.1002/cpdd.717

By:

Liu, Li;
Ding, Yanhua;
Jiao, Zheng;
Wu, Min;
Li, Cuiyun;
Liu, Jingrui;
Liu, Chengjiao;
Hu, Yue;
Li, Qingmei;
Zhang, Hong

Publication type:

Article

Pharmacokinetic Profile of a Generic Formulation of Sofosbuvir and Its Metabolite GS‐331007 in Healthy Chinese Subjects.

Published in:

Clinical Pharmacology in Drug Development, 2019, v. 8, n. 8, p. 1073, doi. 10.1002/cpdd.674

By:

Shen, Zhenwei;
Zhu, Xiaoxue;
Zhang, Hong;
Chen, Hong;
Niu, Junqi;
Chen, Guiling;
Li, Xiaojiao;
Ding, Yanhua

Publication type:

Article

Pharmacokinetics, pharmacodynamics and tolerability of single and multiple doses of janagliflozin, a sodium‐glucose co‐transporter‐2 inhibitor, in Chinese people with type 2 diabetes mellitus.

Published in:

Diabetes, Obesity & Metabolism, 2020, v. 22, n. 12, p. 2316, doi. 10.1111/dom.14156

By:

Li, Xiaojiao;
Zhu, Xiaoxue;
Liu, Jingrui;
Li, Qianqian;
Zhang, Hong;
Li, Cuiyun;
Wu, Min;
Gao, Lei;
Wen, He;
Li, Xixi;
Tang, Xinran;
Liu, Li;
Ding, Yanhua

Publication type:

Article

Pharmacokinetics and pharmacodynamics of rongliflozin, a novel selective inhibitor of sodium‐glucose co‐transporter‐2, in people with type 2 diabetes mellitus.

Published in:

Diabetes, Obesity & Metabolism, 2020, v. 22, n. 2, p. 191, doi. 10.1111/dom.13887

By:

Zhang, Hong;
Zhu, Xiaoxue;
Li, Xiaojiao;
Chen, Hong;
Wu, Min;
Li, Cuiyun;
Liu, Jingrui;
Liu, Chengjiao;
Zhang, Yingjun;
Ding, Yanhua

Publication type:

Article

Parallel domestication with a broad mutational spectrum of determinate stem growth habit in leguminous crops.

Published in:

Plant Journal, 2018, v. 96, n. 4, p. 761, doi. 10.1111/tpj.14066

By:

Li, Shuai;
Ding, Yanhua;
Zhang, Dajian;
Wang, Xutong;
Tang, Xuemin;
Dai, Deyan;
Jin, Hanqi;
Lee, Suk‐Ha;
Cai, Chunmei;
Ma, Jianxin

Publication type:

Article

HDV Seroprevalence in HBsAg-Positive Patients in China Occurs in Hotspots and Is Not Associated with HCV Mono-Infection.

Published in:

Viruses (1999-4915), 2021, v. 13, n. 9, p. 1799, doi. 10.3390/v13091799

By:

Roggenbach, Imme;
Chi, Xiumei;
Lempp, Florian A.;
Qu, Bingqian;
Walter, Lisa;
Wu, Ruihong;
Gao, Xiuzhu;
Schnitzler, Paul;
Ding, Yanhua;
Urban, Stephan;
Niu, Junqi

Publication type:

Article

Safety, tolerability and pharmacokinetics of forsythin in healthy subjects: a double-blinded, placebo-controlled single-dose and multiple-dose escalation and food effect study.

Published in:

Annals of Medicine, 2023, v. 55, n. 2, p. 1, doi. 10.1080/07853890.2023.2274512

By:

Li, Cuiyun;
Wu, Min;
Zhang, Hong;
Zhu, Xiaoxue;
Fu, Li;
Wang, Shuo;
Lu, Mingming;
Zhong, Dafang;
Ding, Yanhua

Publication type:

Article

Safety, tolerability, pharmacokinetics and pharmacodynamics of a novel farnesoid X receptor (FXR) agonist-TQA3526 in healthy Chinese volunteers: a double-blind, randomized, placebo-controlled, dose-escalation, food effect phase I study.

Published in:

Annals of Medicine, 2023, v. 55, n. 2, p. 1, doi. 10.1080/07853890.2023.2264850

By:

Xu, Jia;
Zhang, Hong;
Chen, Hong;
Zhu, Xiaoxue;
Jia, Haiyan;
Xu, Zhongnan;
Huo, Dandan;
Li, Cuiyun;
Ding, Yanhua

Publication type:

Article

Safety, pharmacokinetics and pharmacodynamics of a novel γ-aminobutyric acid (GABA) receptor potentiator, HSK3486, in Chinese patients with hepatic impairment.

Published in:

Annals of Medicine, 2022, v. 54, n. 1, p. 2757, doi. 10.1080/07853890.2022.2129433

By:

Hu, Yue;
Li, Xiaojiao;
Liu, Jingrui;
Chen, Hong;
Zheng, Wenbo;
Zhang, Hong;
Wu, Min;
Li, Cuiyun;
Zhu, Xiaoxue;
Lou, Jinfeng;
Yan, Pangke;
Wu, Nan;
Liu, Xiao;
Ma, Shiping;
Wang, Xu;
Ding, Yanhua;
Xuan, Chengluan

Publication type:

Article

A randomized phase-I pharmacokinetic trial comparing the potential biosimilar tocilizumab (QX003S) with the reference product (Actemra®) in Chinese healthy subjects.

Published in:

Annals of Medicine, 2021, v. 53, n. 1, p. 375, doi. 10.1080/07853890.2021.1887925

By:

Zhang, Hong;
Li, Xiaojiao;
Liu, Jingrui;
Li, Cuiyun;
Wu, Min;
Zhu, Xiaoxue;
Sun, Jixuan;
Fang, Min;
Ding, Yanhua

Publication type:

Article

A randomized phase-I pharmacokinetic trial comparing the potential biosimilar tocilizumab (QX003S) with the reference product (ActemraVR) in Chinese healthy subjects.

Published in:

Annals of Medicine, 2021, v. 53, n. 1, p. 375, doi. 10.1080/07853890.2021.1887925

By:

Hong Zhang;
Xiaojiao Li;
Jingrui Liu;
Cuiyun Li;
Min Wu;
Xiaoxue Zhu;
Jixuan Sun;
Min Fang;
Yanhua Ding

Publication type:

Article

Population pharmacokinetic/pharmacodynamic models of JNJ-64794964, a toll-like receptor 7 agonist, in healthy adult participants.

Published in:

Antiviral Therapy, 2023, v. 28, n. 1, p. 1, doi. 10.1177/13596535231151626

By:

Wu, Liviawati S;
Hu, Yue;
Gane, Edward J;
Slaets, Leen;
De Creus, An;
Ding, Yanhua;
Niu, Junqi;
Schwabe, Christian;
Goeyvaerts, Nele;
Xu, Zhongnan;
Huo, Dandan;
Tuefferd, Marianne;
Verbrugge, Inge;
Van Remoortere, Pieter;
Schwertschlag, Ullrich;
Vandenbossche, Joris

Publication type:

Article

A phase 1 randomized study compare the pharmacokinetics, safety and immunogenicity of HLX04 to reference bevacizumab sourced from the United States, the European Union, and China in healthy Chinese male volunteers.

Published in:

Cancer Chemotherapy & Pharmacology, 2021, v. 88, n. 3, p. 465, doi. 10.1007/s00280-021-04297-z

By:

Zhu, Xiaoxue;
Qian, Hongjie;
Sun, Jixuan;
Wu, Min;
Yu, Chen;
Ding, Yanhua;
Zhang, Xiaodi;
Chai, Katherine;
Li, Xiaojiao

Publication type:

Article

Randomised clinical trial: safety, efficacy and pharmacokinetics of HS‐10234 versus tenofovir for the treatment of chronic hepatitis B infection.

Published in:

Alimentary Pharmacology & Therapeutics, 2021, v. 53, n. 2, p. 243, doi. 10.1111/apt.16196

By:

Zhang, Hong;
Hu, Yue;
Wu, Min;
Liu, Jingrui;
Zhu, Xiaoxue;
Li, Xiaojiao;
Chen, Hong;
Li, Cuiyun;
Liu, Chengjiao;
Niu, Junqi;
Ding, Yanhua

Publication type:

Article

Computational analysis of naturally occurring resistance-associated substitutions in genes NS3, NS5A, and NS5B among 86 subtypes of hepatitis C virus worldwide.

Published in:

Infection & Drug Resistance, 2019, v. 12, p. 2987, doi. 10.2147/IDR.S218584

By:

Wu, Ruihong;
Geng, Dongfeng;
Chi, Xiumei;
Wang, Xiaomei;
Gao, Xiuzhu;
Xu, Hongqin;
Shi, Ying;
Guan, Yazhe;
Wang, Yang;
Jin, Jinglan;
Ding, Yanhua;
Niu, Junqi

Publication type:

Article

Antiviral Activity and Pharmacokinetics of the Hepatitis B Virus (HBV) Capsid Assembly Modulator GLS4 in Patients With Chronic HBV Infection.

Published in:

Clinical Infectious Diseases, 2021, v. 73, n. 2, p. 175, doi. 10.1093/cid/ciaa961

By:

Zhang, Hong;
Wang, Fengjiao;
Zhu, Xiaoxue;
Chen, Yunfu;
Chen, Hong;
Li, Xiaojiao;
Wu, Min;
Li, Cuiyun;
Liu, Jingrui;
Zhang, Yingjun;
Ding, Yanhua;
Niu, Junqi

Publication type:

Article

A Phase I Study Comparing the Pharmacokinetics, Safety, and Immunogenicity of A140 Injection and Cetuximab (Erbitux®) in Healthy Chinese Male Subjects.

Published in:

Advances in Therapy, 2025, v. 42, n. 6, p. 2797, doi. 10.1007/s12325-025-03193-9

By:

Xu, Jia;
Ge, Junyou;
Li, Yaling;
Liu, Shulin;
Li, Sicong;
Si, Jing;
Liu, Juncheng;
Zhu, Xiaoxue;
Ding, Yanhua

Publication type:

Article

Tolerance, variability, and pharmacokinetics of bevacizumab biosimilars in Chinese healthy male subjects.

Published in:

2018

By:

Zhang, Hong;
Li, Qingmei;
Zhu, Xiaoxue;
Li, Cuiyun;
Li, Xiaojiao;
Liu, Chengjiao;
Hu, Yue;
Chen, Guiling;
Wei, Haijing;
Wang, Jing;
Shen, Zhenwei;
Ding, Yanhua

Publication type:

journal article

Design and experiment on temperature control system of solid-state fermentation of soybean meal based on PLC.

Published in:

Packaging & Food Machinery, 2024, v. 42, n. 2, p. 62, doi. 10.3969/j.issn.1005-1295.2024.02.009

By:

DING Yanhua;
HAN Bo;
ZHANG Hongyun;
LI Yalong;
QU Wenjuan

Publication type:

Article

Flute‐like Fe2O3 Nanorods with Modulating Porosity for High Performance Anode Materials in Lithium Ion Batteries.

Published in:

ChemistrySelect, 2019, v. 4, n. 13, p. 3681, doi. 10.1002/slct.201900584

By:

Liu, Huanqing;
Zou, Jiajia;
Ding, Yanhua;
Xin, Tuo;
Liu, Bing;
Wang, Yiqian

Publication type:

Article

Pharmacokinetics, safety, and immunogenicity of HLX03, an adalimumab biosimilar, compared with reference biologic in healthy Chinese male volunteers: Results of a randomized, double-blind, parallel-controlled, phase 1 study.

Published in:

Pharmacology Research & Perspectives, 2021, v. 9, n. 2, p. 1, doi. 10.1002/prp2.733

By:

Hong Zhang;
Min Wu;
Jixuan Sun;
Xiaoxue Zhu;
Cuiyun Li;
Yanhua Ding;
Xiaodi Zhang;
Katherine Chai;
Xiaojiao Li

Publication type:

Article

An Evaluation of the Pharmacokinetics, Safety, and Tolerability of Aclidinium/Formoterol Fixed-Dose Combination Administered in Chinese Patients with Moderate-to-Severe Chronic Obstructive Pulmonary Disease.

Published in:

Drugs in R&D, 2022, v. 22, n. 1, p. 35, doi. 10.1007/s40268-021-00374-z

By:

Zhang, Hong;
Daoud, Sami Z.;
Gillen, Michael S.;
Calderon, Natalia;
Heijer, Maria;
Molins, Eduard;
Garcia-Gil, Esther;
Chen, Hong;
Li, Qianqian;
Liu, Chengjiao;
Ding, Yanhua

Publication type:

Article

Clinical Targeted Panel Sequencing Analysis in Clinical Evaluation of Children with Autism Spectrum Disorder in China.

Published in:

Genes, 2022, v. 13, n. 6, p. 1010, doi. 10.3390/genes13061010

By:

Hu, Chunchun;
He, Linlin;
Li, Huiping;
Ding, Yanhua;
Zhang, Kaifeng;
Li, Dongyun;
Zhu, Guoqing;
Wu, Bingbing;
Xu, Xiu;
Xu, Qiong

Publication type:

Article

First-in-human study on tolerability, pharmacokinetics and pharmacodynamics of single and multiple escalating doses of XKH001, a recombinant humanized monoclonal antibody against IL-25 in healthy Chinese volunteers.

Published in:

Expert Opinion on Investigational Drugs, 2025, v. 34, n. 1/2, p. 81, doi. 10.1080/13543784.2025.2453162

By:

Zhang, Hong;
Zheng, Wenbo;
Peng, Ran;
Wu, Dandan;
Hu, Yue;
Sun, Tiantian;
Gao, Lei;
Liu, Yusi;
Guo, Li;
Ding, Yanhua;
Liu, Li

Publication type:

Article

The effect of a single escalating dose of long-acting recombinant human follicle-stimulating hormone Fc fusion protein (KN015) on healthy, pituitary-suppressed women: first-in-human and randomized study on its pharmacokinetics, pharmacodynamics, and tolerability

Published in:

Expert Opinion on Investigational Drugs, 2022, v. 31, n. 11, p. 1255, doi. 10.1080/13543784.2022.2151434

By:

Zhang, Hong;
Fan, Yanyan;
Gao, Lei;
Wang, Boguang;
Xu, Ting;
Wu, Min;
Liu, Jingrui;
Zhu, Xiaoxue;
Li, Xiaojiao;
Chen, Hong;
Li, Cuiyun;
Wang, Meng;
Liu, Chengjiao;
Mao, Yanhong;
Yang, Mingtang;
Ding, Yanhua

Publication type:

Article

Pharmacokinetics, safety, and tolerability of TQC3564, a novel CRTh2 receptor antagonist: report of the first-in-human single- and multiple-dose escalation trials in healthy Chinese subjects.

Published in:

Expert Opinion on Investigational Drugs, 2022, v. 31, n. 7, p. 729, doi. 10.1080/13543784.2022.2078192

By:

Li, Xiaojiao;
Li, Qianqian;
Ji, Tianliang;
Zhang, Hong;
Liu, Jingrui;
Wu, Min;
Chen, Hong;
Lou, Jinfeng;
Liu, Chengjiao;
Xu, Zhongnan;
Ding, Yanhua

Publication type:

Article

Safety, tolerability, pharmacodynamics, and pharmacokinetics of CJC-1134-PC in healthy Chinese subjects and type-2 diabetic subjects.

Published in:

Expert Opinion on Investigational Drugs, 2021, v. 30, n. 12, p. 1241, doi. 10.1080/13543784.2021.2008906

By:

Ding, Yanhua;
Zhang, Hong;
Zhu, Xiaoxue;
Wu, Min;
Yang, Lizhi;
Yao, Zhiwen;
Xie, Qiang;
Liu, Xiping;
Li, Cuiyun

Publication type:

Article

Single and multiple dose pharmacokinetics and safety of ZSP1273, an RNA polymerase PB2 protein inhibitor of the influenza A virus: a phase 1 double-blind study in healthy subjects.

Published in:

Expert Opinion on Investigational Drugs, 2021, v. 30, n. 11, p. 1159, doi. 10.1080/13543784.2021.1994944

By:

Hu, Yue;
Li, Haijun;
Wu, Min;
Zhang, Hong;
Ding, Yanhua;
Peng, Yun;
Li, Xiaojiao;
Yu, Zhenxiang

Publication type:

Article

Safety, tolerability, and pharmacokinetics of the novel pan-phosphodiesterase inhibitor ZSP1601 in healthy subjects: a double-blinded, placebo-controlled first-in-human single-dose and multiple-dose escalation and food effect study.

Published in:

Expert Opinion on Investigational Drugs, 2021, v. 30, n. 5, p. 579, doi. 10.1080/13543784.2021.1900822

By:

Zhu, Xiaoxue;
Wu, Min;
Wang, Hong;
Li, Haijun;
Lin, Junjie;
Peng, Yun;
Hu, Yue;
Li, Cuiyun;
Ding, Yanhua

Publication type:

Article

Safety, pharmacokinetics and pharmacodynamics of TQ-A3334, an oral toll-like receptor 7 agonist in healthy individuals.

Published in:

Expert Opinion on Investigational Drugs, 2021, v. 30, n. 3, p. 263, doi. 10.1080/13543784.2021.1873275

By:

Hu, Yue;
Zhang, Hong;
Wu, Min;
Liu, Jingrui;
Li, Xiaojiao;
Zhu, Xiaoxue;
Li, Cuiyun;
Chen, Hong;
Liu, Chengjiao;
Niu, Junqi;
Ding, Yanhua

Publication type:

Article

Pharmacokinetics and pharmacodynamics of MT-1207, a novel multitarget blocker of α1 receptor, 5-HT2A receptor, and calcium channel, in healthy subjects.

Published in:

Expert Opinion on Investigational Drugs, 2021, v. 30, n. 3, p. 271, doi. 10.1080/13543784.2021.1887137

By:

Zhang, Hong;
Wu, Min;
Hu, Yue;
Li, Cuiyun;
zheng, Wenbo;
Liu, Jingrui;
Li, Xiaojiao;
Zhu, Xiaoxue;
Ding, Yanhua

Publication type:

Article

Safety and pharmacokinetics of a biosimilar of denosumab (KN012): Phase 1 and bioequivalence study in healthy Chinese subjects.

Published in:

Expert Opinion on Investigational Drugs, 2021, v. 30, n. 2, p. 185, doi. 10.1080/13543784.2021.1863371

By:

Zhang, Hong;
Li, Cuiyun;
Liu, Jingrui;
Wu, Min;
Li, Xiaojiao;
Zhu, Xiaoxue;
Li, Qianqian;
Wang, Boguang;
Mao, Yanhong;
Ding, Yanhua;
Jin, Qinglong

Publication type:

Article

A Phase I, Randomized, Double-Blind, Single-Dose, Parallel-Group Study to compare Pharmacokinetic Similarity, Safety, and Immunogenicity Between BAT2506 and Golimumab in Healthy Chinese Male Subjects.

Published in:

Expert Opinion on Investigational Drugs, 2021, v. 30, n. 1, p. 77, doi. 10.1080/13543784.2021.1851364

By:

Wu, Min;
Sun, Jixuan;
Wu, Dandan;
Xu, Jia;
Wei, Jin;
Wang, Zhaohe;
Yu, Jinchen;
Li, Shengfeng;
Zhang, Hong;
Ding, Yanhua

Publication type:

Article

PCSK9 inhibitor recaticimab for hypercholesterolemia on stable statin dose: a randomized, double-blind, placebo-controlled phase 1b/2 study.

Published in:

2022

By:

Xu, Mingtong;
Zhu, Xiaoxue;
Wu, Junyan;
Zhang, Yuling;
Zhao, Dong;
Wang, Xuhong;
Ding, Yanhua;
Cao, Yu;
Li, Chengqian;
Hu, Wei;
Sheng, Jianlong;
Luo, Zhu;
Zheng, Zeqi;
Hu, Jinfang;
Liu, Jianying;
Zhou, Xiaoyang;
Shen, Aizong;
Ding, Xiaomei;
Zhang, Yongdong;
Zhao, Yonggang

Publication type:

journal article

SnO2 nanocrystal-Fe2O3 nanorod hybrid structures: an anode material with enhanced lithium storage capacity.

Published in:

Journal of Solid State Electrochemistry, 2019, v. 23, n. 2, p. 379, doi. 10.1007/s10008-018-4133-6

By:

Li, Tao;
Xin, Tuo;
Ding, Yanhua;
Zou, Jiajia;
Liu, Huanqing;
Liu, Bing;
Wang, Yiqian

Publication type:

Article

A Phase I, Randomized, Single-Dose Study to Evaluate the Biosimilarity of HOT-3010 to Adalimumab Among Healthy Chinese Male Subjects.

Published in:

Frontiers in Pharmacology, 2021, v. 11, p. N.PAG, doi. 10.3389/fphar.2021.646171

By:

Zhang, Hong;
Chen, Hong;
Li, Xiaojiao;
Wu, Min;
Zhu, Xiaoxue;
Li, Cuiyun;
Liu, Jingrui;
Wei, Haijing;
Hu, Yue;
Wang, Jingjing;
Yang, Yongmin;
Zhu, Xiangyang;
Ding, Yanhua

Publication type:

Article

Phase I Trial to Evaluate the Tolerance, Pharmacokinetics and Efficacy of the Broad-Spectrum ErbB Family Inhibitor Larotinib Mesylate in Patients With Advanced Solid Tumors.

Published in:

Frontiers in Pharmacology, 2021, v. 11, p. N.PAG, doi. 10.3389/fphar.2021.636324

By:

Liu, Jingrui;
Zhang, Hong;
Zhu, Xiaoxue;
Chen, Hong;
Li, Xiaojiao;
Ding, Yanhua

Publication type:

Article

A Phase I Clinical Study Comparing the Tolerance, Immunogenicity, and Pharmacokinetics of Proposed Biosimilar BAT1806 and Reference Tocilizumab in Healthy Chinese Men.

Published in:

Frontiers in Pharmacology, 2021, v. 11, p. N.PAG, doi. 10.3389/fphar.2020.609522

By:

Zhang, Hong;
Wang, Hong;
Wei, Haijing;
Chen, Hong;
Liu, Jingrui;
Li, Cuiyun;
Zhu, Xiaoxue;
Li, Xiaojiao;
Yu, Jinchen;
Zhou, Yinbo;
Yang, Xiaolei;
Wang, Zhaohe;
Wu, Min;
Ding, Yanhua

Publication type:

Article

A Phase I, Randomized, Double-Blind, Placebo-Controlled, Single Ascending Dose, Multiple Ascending Dose and Food Effect Study to Evaluate the Tolerance, Pharmacokinetics of Jaktinib, a New Selective Janus Kinase Inhibitor in Healthy Chinese Volunteers.

Published in:

Frontiers in Pharmacology, 2020, v. 11, p. N.PAG, doi. 10.3389/fphar.2020.604314

By:

Liu, Jingrui;
Lv, Binhua;
Yin, Hewen;
Zhu, Xiaoxue;
Wei, Haijing;
Ding, Yanhua

Publication type:

Article

A Phase I, Randomized, Single-Dose Study to Evaluate the Biosimilarity of QL1206 to Denosumab Among Chinese Healthy Subjects.

Published in:

Frontiers in Pharmacology, 2020, v. 11, p. N.PAG, doi. 10.3389/fphar.2020.01329

By:

Zhang, Hong;
Wu, Min;
Zhu, Xiaoxue;
Li, Cuiyun;
Li, Xiaojiao;
Sun, Jixuan;
Liu, Chengjiao;
Liu, Quan;
Wei, Wei;
Niu, Junqi;
Ding, Yanhua

Publication type:

Article

Impacts of CYP2C19 genetic polymorphisms on bioavailability and effect on platelet adhesion of vicagrel, a novel thienopyridine P2Y12 inhibitor.

Published in:

British Journal of Clinical Pharmacology, 2020, v. 86, n. 9, p. 1860, doi. 10.1111/bcp.14296

By:

Zhang, Yifan;
Zhu, Xiaoxue;
Zhan, Yan;
Li, Xiaojiao;
Liu, Cai;
Zhu, Yunting;
Zhang, Hong;
Wei, Haijing;
Xia, Yu;
Sun, Hongbin;
Liu, Yongqiang;
Lai, Xiaojuan;
Gong, Yanchun;
Liu, Xuefang;
Li, Yongguo;
Ding, Yanhua;
Zhong, Dafang

Publication type:

Article

Tolerability, pharmacokinetics and antiviral activity of rHSA/IFNα2a for the treatment of chronic hepatitis B infection.

Published in:

British Journal of Clinical Pharmacology, 2017, v. 83, n. 5, p. 1056, doi. 10.1111/bcp.13184

By:

Ding, Yanhua;
Lou, Jinfeng;
Chen, Hong;
Li, Xiaojiao;
Wu, Min;
Li, Cuiyun;
Liu, Jingrui;
Liu, Chengjiao;
Li, Qingmei;
Zhang, Hong;
Niu, Junqi

Publication type:

Article

First-In-Human Study on Pharmacokinetics, Safety, and Tolerability of Single and Multiple Escalating Doses of Hepenofovir, a Novel Hepatic Targeting Prodrug of Tenofovir in Healthy Chinese Subjects.

Published in:

Frontiers in Pharmacology, 2022, v. 13, p. 1, doi. 10.3389/fphar.2022.873588

By:

Zhang, Hong;
Gao, Lei;
Lou, Jinfeng;
Wu, Min;
Chen, Hong;
Yang, Lizhi;
Liu, Jingrui;
Zhu, Xiaoxue;
Li, Xiaojiao;
Li, Cuiyun;
Wang, Meng;
Liu, Chengjiao;
Guo, Weibo;
Wang, Yuan;
Gao, Zhongqiang;
Han, Lei;
Wang, Daidi;
Jin, Weili;
Ding, Yanhua

Publication type:

Article

Pharmacokinetics, Pharmacodynamics, Safety, Tolerability, and Immunogenicity of the QX002N anti-IL-17 Monoclonal Antibody: A Phase I, Randomized, Double-Blind, Single Ascending Dose Study in Healthy Chinese Volunteers.

Published in:

Frontiers in Pharmacology, 2022, v. 13, p. 1, doi. 10.3389/fphar.2021.794054

By:

Wu, Min;
Zhang, Hong;
Li, Qianqian;
Chen, Hong;
Fang, Min;
Yang, Lizhi;
Ding, Yanhua

Publication type:

Article